Patents by Inventor Lukas Christoph Bachmann

Lukas Christoph Bachmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240216544
    Abstract: Provided herein are compositions and systems for reconstitution of RNA molecules, including methods for using these molecules. For example, such molecules can be used to deliver a protein coding sequence over two or more viral vectors (such as AAVs), resulting in reconstitution of the full-length protein in a cell. Such methods can be used to deliver a protein involved in editing a nucleic acid molecule, for example to treat a genetic disease or cancer.
    Type: Application
    Filed: May 16, 2022
    Publication date: July 4, 2024
    Applicant: Salk Institute for Biological Studies
    Inventors: Lukas Christoph Bachmann, Samuel Lawrence Pfaff
  • Publication number: 20220265855
    Abstract: Provided herein are compositions and systems for reconstitution of RNA molecules, including methods for using these molecules. For example, such molecules can be used to deliver a protein coding sequence over two or more viral vectors (such as AAVs), resulting in reconstitution of the full-length protein in a cell. Such methods can be used to deliver a therapeutic protein, for example to treat a genetic disease or cancer.
    Type: Application
    Filed: May 10, 2022
    Publication date: August 25, 2022
    Applicant: Salk Institute for Biological Studies
    Inventors: Lukas Christoph Bachmann, Samuel Lawrence Pfaff
  • Publication number: 20220145347
    Abstract: Provided herein are synthetic RNA molecules for reconstitution of RNA molecules, including compositions and methods of using these molecules. For example, such molecules can be used to deliver a protein coding sequence over two or more viral vectors (such as AAVs), resulting in reconstitution of the full-length protein in a cell. Such methods can be used to deliver a therapeutic protein, for example to treat a genetic disease or cancer.
    Type: Application
    Filed: September 27, 2021
    Publication date: May 12, 2022
    Applicant: Salk Institute for Biological Studies
    Inventors: Lukas Christoph Bachmann, Samuel Lawrence Pfaff